Danggeun Market Inc.’s buying and selling app Karrot has raised $162 million from investors including DST Global, to record a $2.7 billion valuation and makes it one of the largest startups in South Korea.
Karrot is backed by a venture arm of Masayoshi Son’s SoftBank Group Corp. and the new round. It now joins a list of South Korean unicorns eyeing global expansion as growth at home plateaus.
Karrot’s new investors include Yuri Milner’s outfit and Aspex Management. Its existing investors like Altos Ventures and Goodwater Capital also participated.\
Like other South Korean startups such as Coupang Inc. and Krafton Inc., Karrot is preparing to expand internationally.
South Korean startups can also become successful like Facebook and Google as the quality of their products, marketing, and branding have all matured, said Karrot co-founder Gary Kim.
He added that there would soon be a Korean consumer app that would be used globally.
Kim said the new funds would finance Karrot’s talent acquisition and overseas expansion plans for the next 18 months to two years.
The 200-person Karrot intends to add 100 new employees this year.
The company is focusing on improving profitability, and it may take five years before any potential public listing. While its local ad sales business is growing, Karrot is not yet profitable.
Karrot handled hundreds of billions of dollars of sales last year, according to Kim.


China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



